Small Molecules for Cancer Targets – Part 1


Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules offer the promise of medicine in pill form and more affordability than do biologics, but they also expand the types of cancers that can be treated due to their ability to better penetrate the tumor microenvironment (TME) and their ability to enter the cell and reach intracellular targets. Cambridge Healthtech Institute's 5th Annual back-to-back Small Molecules for Cancer Targets conferences showcase the small molecule compounds making progress in oncology. Our expanded coverage via Part 1 and Part 2 reflects the increased number of cellular and immunological oncology mechanisms and targets being uncovered and new discovery chemistry and biology advances enabling progress in modulating them.

Similar Events

You May Like

12-17 December 2023
2023 Evolution of Psychotherapy
13-16 December 2023
Antibody Engineering & Therapeutics US
14-16 December 2023
Advances in Inflammatory Bowel Diseases conference
23-24 January 2024
5th Edition Excellence in Real World Evidence and Data Utilization
06-07 March 2024
The 11th Edition of Mexico Health Summit
15-17 April 2024
Festival of Biologics USA 2024
18-19 April 2024
High Potent Medicines Conference


Cambridge Healthtech Institute


Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

26 - 27 Sep 2023

Speakers and Delegates
Industry Experts and Thought Leaders

Senior Director Protein Sciences and Structural Biology
Institute Scientist and Imaging Platform Senior Director
Chief Executive Officer
Head of Therapeutic Innovation and Drug Discovery
Vice President of Medicinal Chemistry
Senior Vice President, Head of Discovery Sciences
Vice President of Antibody Discovery
Senior Scientist
Head of Chemical Biology, Bayer Research and Innovation Center

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Charles River Laboratories

At Charles River, we are passionate about our role in improving the quality of people’s lives.


We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for quality and integrity.

Reaction Biology

Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.

WuXi AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.

Sai Life Sciences Ltd

Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow.

Pelago Bioscience

Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics.

Sino Biological, Inc.

Established in 2007, Sino Biological is a global biotechnology company manufacturing high quality research reagents for basic, translational, and clinical research.


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face.

BPS Bioscience Inc.

BPS manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, inhibitor assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products.

AssayQuant Technologies

AssayQuant® mission is to support the development of more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions.

Biointron Biological Inc.

Biointron is a leading high throughput recombinant antibody/protein expression provider. From gene sequence to purified antibodies, it just takes 2 weeks.

Q² Solutions

Q² Solutions is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biospecimen and consent management solutions.


BioDuro-Sundia is a global provider of contract research, development and manufacturing outsourcing solutions.

Biosensing Instrument Inc

Biosensing Instrument is a life science company that designs and supplies award winning label-free molecular interaction instruments based on the Surface Plasmon Resonance technology.

Chemical Computing Group

CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences.

LifeSensors, Inc

LifeSensors, Inc. is a biotechnology company leading the development of innovative research tools and services for the ubiquitin and ubiquitin-like protein pathways.

X-Chem, Inc.

Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery.

Proteome Sciences plc

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids.

Promega Corporation

At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.


Causaly accelerates how humans acquire knowledge and develop insights in Biomedicine.

Apex Molecular Ltd

Apex Molecular is a leading UK based Chemistry Services Contract Research Organisation based at Alderley Park, providing specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors.


We are ChemPartner, an innovative, full-service life science CRO/CDMO providing biopharmaceutical research with a global reach.

Fusion Antibodies

Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.

Pivot Park Screening Centre

Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery.

Genscript Probio

The CDMO segment of the world's leading biotech company GenScript.

Evident Scientific

We are guided by the scientific spirit. Innovation and exploration are at the heart of what we do. Discover what sets us apart.


Get emails from us

Thank you
Oops! Something went wrong